COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The CDC issued a health advisory warning of COVID-19-associated multisystem inflammatory syndrome in children.
CMS recently issued new guidance to states to allow temporary COVID-19-related modifications in provider payment methodologies and capitation rates under Medicaid managed care plans.
The CDC will award $10.25 billion from the Paycheck Protection Program and Health Care Enhancement Act to states, localities and territories by May 23 to expand COVID-19 testing and surveillance activities, the agency announced.
The Centers for Medicare & Medicaid Services issued new guidance to states to allow temporary COVID-19-related modifications in provider payment methodologies and capitation rates under Medicaid managed care plans. Please see the CMS information bulletin to state Medicaid agencies for details.
The Centers for Medicare & Medicaid released a new toolkit of best practices to help nursing homes, states and departments of health address the COVID-19 crisis within nursing homes.
The Centers for Medicare & Medicaid Services has posted a FAQ on the Coronavirus Aid, Relief, and Economic Security Act requirement that providers of COVID-19 diagnostic tests make public the cash price for the tests on their website during the public health emergency.
The Food and Drug Administration authorized the emergency use of the Ascom telecare IP Nurse Call System and Eko electrocardiogram Low Ejection Fraction Tool.
The Centers for Medicare & Medicaid Services May 12 and May 14 will host calls for hospitals, health systems and providers on COVID-19.
Deaths were 75% higher than usual in New York City between March 11 and May 2, with most of the estimated 24,172 increase likely due to COVID-19, according to a report by the New York City Department of Health and Mental Hygiene released by the CDC.
The FDA authorized the emergency use of Fresenius Propoven 2% Emulsion, which the agency says "may be effective to maintain sedation via continuous infusion in patients greater than 16 years old with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting."